化合物UVI 3003 T17209
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 847239-17-2 | ¥3,370.00 | 询底价 |
10 mg | 847239-17-2 | ¥1,730.00 | 询底价 |
5 mg | 847239-17-2 | ¥987.00 | 询底价 |
100 mg | 847239-17-2 | ¥6,930.00 | 询底价 |
1 mL | 847239-17-2 | ¥1,080.00 | 询底价 |
50 mg | 847239-17-2 | ¥4,960.00 | 询底价 |
2 mg | 847239-17-2 | ¥619.00 | 询底价 |
1 mg | 847239-17-2 | ¥433.00 | 询底价 |
Product Introduction
Bioactivity
英文名: UVI 3003
描述: UVI 3003 是一种高度选择性的类视黄醇 X 受体拮抗剂。在 Cos7 细胞中,它抑制非洲爪蟾蜍和人RXRα的活性,IC50值分别为 0.22 和 0.24 μM。
体外活性: UVI3003 fully activates xPPARγ (EC50: 12.6 μM) and is almost completely inactive on hPPARγ and mPPARγ. UVI 3003 causes a 65.4% difference in EECD34 cell fusion and desmin expression. UVI 3003 (10 μM) does not change the proliferation rate of extraocular muscles (EOM)-derived or LEG-derived EECD34 cells [1][2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 100 mg/mL (229.05 mM)
关键字: UVI3003 | Retinoid X receptors | Autophagy | RAR/RXR | UVI-3003 | Inhibitor | Retinoic acid receptors | inhibit | UVI 3003
相关产品: Bigelovin | Tamibarotene | Fluorobexarotene | Oxybenzone | BMS 195614 | Tarenflurbil | Bexarotene | PA452 | Cecropin B acetate | AC-55649
相关库: Neuronal Differentiation Compound Library | Anti-Metabolism Disease Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Nuclear Receptor Compound Library | Autophagy Compound Library | Metabolism Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物UVI 3003 T17209信息由TargetMol中国为您提供,如您想了解更多关于化合物UVI 3003 T17209报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途